Increased basal tone and hyperresponsiveness to acetylcholine and ergonovine in spasm-related coronary arteries in patients with variant angina

International Journal of Cardiology

Volumn 55, Issue 2, 1996, Pages 117-126

  Lee, Simon Jong Koo ^a   Park, Seung Jung ^a   Park, Seong Wook ^a   Kim, Jae Joong ^a   Song, Jae Kwan ^a   Hong, Myeong Ki ^a   Kang, Duk Hyun ^a   Cheong, Sang Sig ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Basal coronary artery tone; Variant angina

Indexed keywords

ACETYLCHOLINE; ERGOMETRINE;

ADULT; ARTERY TONE; ARTICLE; BLOOD VESSEL TONE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SPASM; DOSE RESPONSE; DRUG RESPONSE; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRACARDIAC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; VARIANT ANGINA PECTORIS; VASOCONSTRICTION;

EID: 0030602868     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02616-2     Document Type: Article

References (31)

1. [1] Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation 1989; 80: 1-9.
2. [2] Yasue H, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Circulation 1990; 81: 482-490.
3. [3] Brown BG. Coronary vasospasm: observation linking the clinical spectrum of ischemic heart disease to the dynamic pathology of coronary atherosclerosis. Arch Intern Med 1981; 141: 716-722.
4. [4] Hackett D, Larkin S, Chierchia S, Davies G, Kaski JC, Maseri A. Induction of coronary spasm by a direct local action of ergonovine. Circulation 1987; 75: 577-582.
5. [5] Hill JA, Feldman RL, Pepine CJ, Conti CR. Regional coronary artery dilation response in variant angina. Am Heart J 1982; 104: 226-233.
6. [6] Hosio A, Kotake H, Mashiba H. Significance of coronary artery tone in patients with vasospastic angina. J Am Coll Cardiol 1989; 14: 604-609.
7. [7] Kaski JC, Maseri A, Vejar M, Crea F, Hackett D. Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. J Am Coll Cardiol 1989; 14: 1456-1463.
8. [8] Kaski JC, Tousoulis D, Gavrielides S, Mcfadden E, Galassi AR, Crea F, Maseri A. Comparison of epicardial coronary artery tone and reactivity in Prinzmetal's variant angina and chronic stable angina pectoris. J Am Coll Cardiol 1991; 17: 1058-1062.
9. [9] AHA Committee Report. A reporting system on patients evaluated for coronary artery disease. Circulation 1975; 51: 5-40.
10. [10] Hoshio A, Miyakoda H, Fukki M, Yamasaki J, Kotake H, Mashiba H. Significance of coronary artery tone assessed by coronary responses to ergonovine and nitrate. Jpn Circ J 1991; 55: 33-40.
11. [11] Yasue H, Omoto S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circardian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise induced coronary artery spasm. Circulation 1979; 59: 938-948.
12. [12] Kuga T, Egashira K, Inoue T, Takeshia A. Correlation of basal coronary tone with constrictive response to ergonovine in patients with variant angina. J Am Coll Cardiol 1993; 22: 144-150.
13. [13] Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res 1983; 53: 557-573.
14. [14] Kalsner S. Cholinergic mechanisms in human coronary artery preparations: implications of species differences. J Physiol (Lond) 1985; 358: 509-526.
15. [15] Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium dependent relaxation and cyclic-guanosin 5′metaphosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987; 79: 170-174.
16. [16] Habib JB, Wells SL, Williams CL, Henry PD. Atherosclerosis impairs endothelium-dependent arterial relaxation (Abstr.). Circulation 1984; 70: 123.
17. [17] Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987; 80: 1808-1811.
18. [18] Ludmer PL, Selwyn AP, SShook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical acetylcholine-induced coronary artery constriction in patients with coronary artery disease. N Engl J Med 1986; 315: 1046-1051.
19. [19] Maseri A, Chierchia S. Coronary artery spasm: demonstration, definition, diagnosis and consequences. Prog Cardiovasc Dis 1982; 25: 169-191.
20. [20] Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. The coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-497.
21. [21] Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989; 79: 287-291.
22. [22] Brazenor RM, Angus JA. Ergometrine contracts isolated canine arteries by a serotonergic mechanism: No role for α-adrenoreceptors. J Pharmacol Exp Ther 1981; 218: 530-536.
23. [23] Griffith TM, Hughes Edwards DH, Lewis MJ, Henderson AH. Ergometrine induced arterial dilatation: an endothelium-mediated effect. J Moll Cell Cardiol 1984; 16: 479-482.
24. [24] Muller-Schweinitzer E. The mechanism of ergonovine induced coronary arterial spasm: in vitro studies on canine arteries. J Cardiovasc Pharmacol 1980; 2: 645-655.
25. [25] Shimokawa H, Flavahan NA, Shepherd JT, Vanhoutte PM. Endothelium-dependent inhibition of ergonovine induced contraction is impaired in porcine coronary arteries with regenerated endothelium. Circulation 1989; 80: 643-650.
26. [26] Egashira K, Tomoike H, Hayashi Y, Yamada A, Makamura M, Takeshida A. Mechanism of ergonovine-induced hyperconstriction of the large epicardial coronary artery in conscious dogs a month after arterial injury. Circ Res 1992; 71: 435-442.
27. [27] Henry PD, Yokoyama M. Supersensitivity of atherosclerotic rabbit aorta to ergonovine: mediated by a serotonergic mechanism. J Clin Invest 1980; 66: 306-313.
28. [28] Kawachi Y, Tomoike H, Maruoka Y, Kikuchi V, Araki H, Ishii Y, Taneka K, Nakamura M. Selective hypercontraction caused by ergonovine in the canine coronary artery under conditions of induced atherosclerosis. Circulation 1984; 69: 441-450.
29. [29] Shimokawa H, Tomoike H, Nabeyama S, Yamamoto H, Ishii Y, Taneka K, Nakamura M. Coronary artery spasm induced in miniature swine: angiographic evidence and relation to coronary atherosclerosis. Am Heart J 1985; 110: 330-310.
30. [30] Yokoyama H, Akita H, Mizutani T, Fukuzaki H, Watanabe. Hyperreactivity of coronary arterial smooth muscles in response to ergonovine from rabbits with hereditary hyperlipidemia. Circ Res 1983; 53: 63-71.
31. [31] Matsuda Y, Moritani K, Ogawa H et al. Response of the coronary artery to a small dose of ergonovine in variant angina. Am Heart J 1986; 112: 947-952.